Bayer Announces Publication of Larotrectinib Data in The New England Journal of Medicine

February 21, 2018

Responsive image

WHIPPANY, N.J., Feb. 21, 2018 /PRNewswire/ — Bayer and Loxo Oncology, Inc., (NASDAQ: LOXO) today announced the publication in The New England Journal of Medicine (NEJM) of larotrectinib data for pediatric and adult patients whose tumors harbor Neurotrophic Tyrosine Receptor Kinase (NTRK)…

Category: Precious Metals